Press Release Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update 9 hours ago
Press Release Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics Aug 12